RESEARCH TRIANGLE PARK, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE:ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced its operating and financial results for the fourth quarter and full year 2023. Full Year Highlights Completed in vivo evaluation of the LUNA™ Surgical System by nine independent surgeons through thirteen procedures across gynecology, urology, and general surgeryOver 3,550 surgical procedures were performe ...

RESEARCH TRIANGLE PARK, N.C., March 15, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced today that it plans to release fourth quarter and full year 2023 financial and operating results after the market closes on Thursday, March 21, 2024. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast. To ...

RESEARCH TRIANGLE PARK, N.C., March 15, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced today that it plans to release fourth quarter and full year 2023 financial and operating results after the market closes on Thursday, March 21, 2024. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast. To ...

A downtrend has been apparent in Asensus Surgical (ASXC) lately with too much selling pressure. The stock has declined 25.2% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.Here is How to Spot Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, fo ...

With so many question marks facing the viability of the equities sector, concerned investors may want to turn their attention to compelling healthcare stocks. Primarily, the sector benefits from permanent relevance. It’s in a nation’s best interest to keep its citizenry healthy and productive, meaning that there will always be funds directed toward the broader health and wellness space.Another factor that could bolster healthcare stocks is its relative insulation from the economy. Now, don’t get me wrong – ...

Asensus Surgical, Inc. (ASXC) achieved a new milestone in the development of its second-generation surgical robotic system, LUNA. The recently conducted Surgeon Lab in Research Triangle Park, NC allowed nine surgeons to conduct in vivo evaluations across various procedures, including gynecology, urology and general surgery.This marked a pivotal step in LUNA's evolution in the booming field of surgical robotics.More on the NewsAsensus Surgical highlighted the positive responses received from participating su ...

Asensus Surgical, Inc. (NYSE:ASXC) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Mark Klausner - IR, Westwicke Partners Anthony Fernando - President and CEO Shameze Rampertab - CFO Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Ross Osborn - Cantor Fitzgerald Operator Good afternoon and welcome to the Asensus Surgical Inc. Third Quarter Financial and Operating Result Conference Call. At this time, all participants are in a listen-only mode. Followi ...

Table of Contents Title of each class Trading symbol Name of each exchange on which registered Common Stock $0.001 par value per share ASXC NYSE American UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________ FORM 10-Q _________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO S ...

Asensus Surgical, Inc. (NYSE:ASXC) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Mark Klausner - Westwicke Partners Anthony Fernando - President and Chief Executive Officer Shameze Rampertab - Chief Financial Officer Conference Call Participants RK Ramakanth - H.C. Wainwright & Co. Operator Good afternoon, and welcome to the Asensus Surgical Second Quarter 2023 Business and Financial Update Call. All participants will be in listen-only mode. [Operator Instructions] After to ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | |--------------------------------------------------------------------------------------------| | For the transition period from | | Commission File Number 0-19437 | | ASENSUS ...